VECTOR NEUROSCIENCES
Vector Neurosciences develops Phase 2 clinical development for Parkinson’s disease.
Similar Organizations
ParkCell
ParkCell is a development of new diagnostics and cell-based therapies for Parkinson’s Disease.
More informations about "Vector Neurosciences"
Vector Neurosciences - Crunchbase Company Profile & Funding
Vector Neurosciences develops Phase 2 clinical development for Parkinson’s disease.See details»
Vector Neurosciences Company Profile 2024: Valuation, Investors ...
Information on acquisition, funding, investors, and executives for Vector Neurosciences. Use the PitchBook Platform to explore the full profile.See details»
MeiraGTx Announces Acquisition of Vector Neurosciences, Gains …
LONDON and NEW YORK, Oct. 09, 2018 (GLOBE NEWSWIRE) -- MeiraGTx Holdings Plc (NASDAQ:MGTX), a vertically integrated, clinical stage gene therapy company, today …See details»
MeiraGTx acquires Vector Neurosciences - 2018-10-05 - Crunchbase
Oct 5, 2018 · Vector Neurosciences Vector Neurosciences develops Phase 2 clinical development for Parkinson’s disease. Acquiring Organization: MeiraGTx MeiraGTx is a …See details»
Vector Neurosciences Inc - Company Profile and News
Vector Neurosciences Inc. provides specialty pharma services. The Company offers clinical stage product candidates to include adeno-associated virus encoding glutamic acid decarboxylase...See details»
Vector Neurosciences - Products, Competitors, Financials, …
Oct 9, 2018 · Vector Neurosciences develops a phase 2 gene therapy program for Parkinson's disease. You're one click away from the most comprehensive, unmatched analyst expertise in …See details»
Vector Neurosciences, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Vector Neurosciences, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»
Gene Therapy Company MeiraGTx Buys Vector Neurosciences for …
Oct 9, 2018 · MeiraGTx, headquartered in London, UK, acquired Vector Neurosciences in an all-stock deal. As part of the deal, MeiraGTx picks up Vector’s Phase II gene therapy program for …See details»
CLINICAL TRIAL HIGHLIGHTS: 1. GENE THERAPY FOR …
In October 2018, MeiraGTx acquired the vector company (Vector Neurosciences Inc.) and as a result acquired clinical development of the AAV-GAD therapy [5]. According to the company …See details»
Vector Neurosciences - Crunchbase
Vector Neurosciences develops Phase 2 clinical development for Parkinson’s disease.See details»
Meiragtx expands its ambitions with Vector Neurosciences buy, …
Dec 10, 2018 · Just months after its Nasdaq debut in June, Meiragtx Holdings plc put its relatively new shares to work in an all-stock-based acquisition of Vector Neurosciences Inc. Announced …See details»
Home - Vector Institute for Artificial Intelligence
Driving research excellence and leadership in AI to foster economic growth. The Vector Institute is an independent, not-for-profit corporation dedicated to AI research. We work across sectors to …See details»
Vector Scholarship in AI - Vector Institute for Artificial Intelligence
Fund your Master’s degree with the Vector Scholarship in AI! Get on our mailing list for exclusive updates. Vector has awarded over 567 Scholarships in AI since the program launched in 2018.See details»
Neuroscientists use AI to simulate how the brain makes sense of …
May 28, 2024 · A research team at Stanford’s Wu Tsai Neurosciences Institute has made a major stride in using AI to replicate how the brain organizes sensory information to make sense of …See details»
Neuronal vector coding in spatial cognition | Nature Reviews …
Aug 6, 2020 · Here, we review the explicit encoding of vectorial information by neurons in and around the hippocampal formation, far from the sensory periphery. The parahippocampal, …See details»
Vector trace cells in the subiculum of the hippocampal formation
Dec 21, 2020 · Here, we describe a novel neuron type, vector trace cell (VTC), whose firing generates a new vector field when a cue is encountered and a ‘trace’ version of that field for …See details»
Decoding the brain: From neural representations to mechanistic …
Oct 17, 2024 · Understanding how the brain works has been a formidable challenge in neuroscience, but advances at the computational level are now driving us closer. This …See details»
A single-vector intersectional AAV strategy for interrogating …
May 27, 2024 · Here we developed Conditional Viral Expression by Ribozyme Guided Degradation (ConVERGD), an adeno-associated virus-based, single-construct, intersectional …See details»
Vector-Borne Disease Network - Entomological Society of America
Formed in May 2019, the Vector-Borne Disease Network (VBDN) is a stakeholder group of non-profit organizations, including membership and trade associations, vector control groups, and …See details»
The physics of brain network structure, function and control
Mar 27, 2019 · We first describe the organizing principles of brain network architecture instantiated in structural wiring under constraints of spatial embedding and energy …See details»